BioOhio is proud to have a board comprised of some of the most influential leaders in Ohio’s bioscience community. From all corners of the state, and representing many business elements within the life cycle of a company, this leadership assists BioOhio accomplish its mission.
Bill Dunlevy, BioOhio Board Chair, Vice President, Sales & Marketing, EG Industries
Bill is the Vice President of Sales & Marketing for EG Industries in Columbus, Ohio. EG Industries’ medical business unit is EG-GILERO. Before joining EG Industries, Bill spent seven years with Battelle as its Vice President and General Manager for the Consumer, Industrial and Medical business unit. A native Ohioan, Bill has spent his entire career in healthcare, initially working as an ICU Registered Nurse for five years. After business school, he started a 25+ year career in medtech and biopharma with leadership roles in sales, marketing, strategy and general management with Roche Diagnostics, Smiths Medical, Philips/Respironics, Karmel Medical and Hill-Rom. He holds degrees from: Anderson University, AS Nursing; Monmouth University, BS Business Management; and Capital University, MBA.
William S. Ball, M.D., Vice President for Research, Vice President for Health Affairs, Dean of the College of Medicine, Professor of Radiology, Biomedical Engineering and Pediatrics, University of Cincinnati
Dr. Ball received his degree in biochemistry from Louisiana State University, is a graduate of Tulane Medical School, and is board certified in both pediatrics and radiology with certification in Neuroradiology. In 1991, Dr. Ball developed and created the Imaging Research Center at Cincinnati Children’s. Dr. Ball has written over 123 scientific contributions and 11 book chapters. He became chair of the Department of Biomedical Engineering at UC in 2001. Dr. Ball later returned to Cincinnati Children’s Hospital as full-time attending staff neuroradiologist where he continued his research in pediatric cerebrovascular occlusive disease with a focus on Sickle Cell Disease. He returned to the university in 2011 and would become permanent vice-president for research in 2012.
Tim Biro, RPh MBA, Chief Operating Officer, On Target Labs
Tim has entrepreneurial experience in the medical device and pharmaceutical industry serving as the CEO of several companies including SpineMatrix, MORK Process, Therox Pharmaceuticals and OncoImmune. He has also had extensive experience in venture capital, being the Founder and Managing Partner of Ohio Innovation Fund, and a Partner in Reservoir Venture Partners. Prior to his career in venture capital, Tim was with Merck, holding management positions in manufacturing. Tim currently serves on the Board of Directors of DATATRAK and Inspherion, on the Advisory Board for BioOhio and NorTech and on the Leadership Council for the University Hospitals Siedman Cancer Center in Cleveland. Tim holds a BS in Microbiology from Pennsylvania State University, a BS in Pharmacy from Temple University (summa cum laude), and an MBA in Finance and Marketing from the Wharton School of Business (with distinction).
Shauna R. Brummet, Ph.D., President & CEO, BioHio Research Park, an Affiliate of The Ohio State University, College of Food, Agricultural and Environmental Sciences
Dr. Brummet has broad experience in life science research and product development, startup and global companies, innovation and technology commercialization, technology-based economic development, and open innovation. Shauna is highly collaborative and connected in the innovation ecosystem. Development and commercialization of new technology, creation of teams and organizations, public-private partnerships, entrepreneurial coaching, innovation and entrepreneurship in higher education and open innovation are key areas of her expertise. Shauna is a graduate of Purdue University (BS in Microbiology), University of Akron (MS, PhD in Analytical and Biochemistry), and post-doctoral work in molecular biology at The Ohio State University Ohio Agricultural Research & Development Center. Previous employers include United States Biochemical, Amersham Life Sciences, Edison Biotechnology Center/BioOhio, NineSigma, and Fluence Therapeutics (founder).
Susan Colby, Director of Human Resources, Alkermes
Susan currently serves as the Director of Human Resources for Alkermes, Inc., a biotechnology and pharmaceutical manufacturing company in Wilmington, Ohio. Previously, she was the Human Resources Business Partner for Clopay Plastic Products Company in Augusta, KY and Nashville, TN, and started her HR career with NCR in Pennsylvania. Susan has her undergraduate degree in Business Administration from The University of Michigan, and a Masters of Human Resource Development from Xavier University. She is immediate past president of the Human Resources Association of Southwestern Ohio.
Jennifer Fillman, VP/GM, Specialty Services at Cardinal Health
Jennifer Fillman oversees Cardinal Health Specialty Solutions’ capabilities in medication access and patient support, healthcare marketing and analytics, third-party logistics and strategic accounts. Prior to her current role, she held several other finance and operations roles at Cardinal Health, most recently serving as vice president of Finance for the company’s Specialty Solutions business. Jennifer received her BA in Economics from Ohio Wesleyan University and her MBA from University of Dayton.
Scott Gaines, SVP & General Manager, Provider Solutions, CoverMyMeds
Scott has extensive business development, consulting and implementation experience in health IT. He currently leads the electronic health record (EHR) and health systems business for CoverMyMeds, the nation’s largest electronic prior authorization platform. Prior to CoverMyMeds, Scott spent nearly 10 years with Hyland, the creator of OnBase, where he most recently led an expansion into international markets. In this role, Scott had the opportunity to advise world-renown healthcare organizations in Europe, the Middle East, Asia and Australia. Scott is an active member of the CHIME Foundation, HIMSS (national), and Central & Southern Ohio HIMSS (local chapter). Scott holds numerous industry credentials, including a Certified Professional in Health Information and Management Systems (CPHIMS) certification, and has a Bachelor of Science degree in Finance from Miami University.
John Gorski, President & CEO, NAMSA
Mr. Gorski has been President and CEO of NAMSA since 2006. He earned his undergraduate degree in economics from Indiana University and law degree from California Western School of Law in San Diego. Mr. Gorski served as a Deputy District Attorney for the San Diego County District Attorneys’ office in the early 1990s and held roles in commercial law firms. After joining NAMSA in 1992, Mr. Gorski began in sales and business development, then grew to oversee several corporate legal and administrative functions which included regulatory submissions, interactions with FDA and other international bodies, Information Technology and Human Resource units. In 2002, Mr. Gorski became Operations Manager over NAMSA’s Northwood, Ohio laboratories and was later promoted to Vice President, Operations, overseeing all of NAMSA’s laboratory operations. Mr. Gorski is a former member of the California, Georgia, and Ohio Bars, and sits on several Boards of Directors/Trustees, both for-profit and not-for-profit including the Toledo Opera Association Endowment, Young President’s Organization and BioOhio.
Stephanie Harrington, MS, CEO, Matrix Medical Devices
Matrix Medical Device founder and visionary, Stephanie Harrington has over 20 years of management experience in the medical device industry, including regulatory affairs, quality system compliance, clinical studies, product development, and commercialization. Guiding startups and established companies alike through new product development and regulatory affairs management is her current mission. Previously, Stephanie served as Chief Operating Officer of Frantz Medical Development, responsible for new product development, manufacturing, and corporate regulatory and quality affairs. Stephanie also served as Vice President and Chief Regulatory Officer at Imalux, establishing the company’s quality system, 510(k) clearances and clinical studies. Prior to Imalux, she was Director, Research and Development at STERIS, responsible for product development of medical device reprocessing systems. Stephanie earned a Masters in Chemical Engineering from Stanford University and holds a BS in Chemical Engineering from the University of Maryland.
Mike Hooven, President and CEO, Enable Injections
Mike has extensive experience in the medical device industry in a broad variety of technical and clinical areas. He is the founder of five medical device companies and holds over 85 issued and pending US patents. Enable Injections is a start-up company focusing on painless injections for vaccines and other drugs. Enable Medical Technologies is a start-up company focusing on opportunities in minimally invasive procedures. Mike is the founder, and a Director of AtriCure, Inc., a medical device company that manufactures and sells surgical devices designed to create precise lesions in soft tissue. He was Director of Product Development at Ethicon Endo-Surgery from 1988 to 1994, and held engineering positions at Siemens/Pacesetter from 1986 to 1988, and at Cordis Corporation from 1981 to 1986. Mike earned a Bachelor of Science in Physics and a Master of Science in Mechanical Engineering from the University of Michigan.
Peter Kleinhenz has been actively involved in technology-based businesses as an entrepreneur, consultant, and investor for virtually all his professional career and specifically in the life sciences sector for over 20 years. Prior to joining CID in 2001, he served as Vice President of Commercialization for Battelle Memorial Institute. He was CEO and owner of Progenics, a medical device development and manufacturer. At Neoprobe Corporation, he was part of the founding management team and served in a variety of senior executive positions including CFO, Vice President of Manufacturing, and Vice President of Strategic Planning and Business Development. Peter received an MBA from Case Western Reserve University, his undergraduate degree from Loyola University of Chicago, and is a Certified Public Accountant licensed in Ohio.
John F. Lewis, Jr., President and CEO, BioOhio
John Lewis, a 4th generation Ohioan, is the President and CEO of BioOhio, Ohio’s bioscience membership organization. He is a licensed attorney with experience in international business, venture capital investments and economic development. He was a founding partner of the First Fifty Fund and Ohio TechAngel Fund. John has more than 18 years international experience, lived in Jamaica, Korea and China, the latter two with Perkin Elmer, while traveling to more than 42 others. John is a graduate of Miami University (Ohio) and Capital University Law School.
Geoff Morgan, Vice President & General Manager, Quidel
Geoff has been with Quidel/Diagnostic Hybrids since 2003, serving as Vice President and Chief Financial Officer, and most recently as Vice President and General Manager. Prior to Quidel, Geoff was with Blue Chip Broadcasting and PricewaterhouseCoopers, both in the Cincinnati area, for 15 years. Geoff is a graduate of Miami University and University of Tulsa (Oklahoma).
Stephen Norton, Senior Director, Corporate Communications and Government Affairs, STERIS
Stephen Norton has over 20 years experience in communications and government affairs with several large- and mid-cap publicly traded corporations. Norton currently advises STERIS Corporation leadership on strategy for communications and government affairs programs. He is responsible for proactively creating, leading and coordinating all communication activities to protect and enhance the company’s brand and global reputation. He is responsible for identifying and coordinating regulatory and legislative policy development activities for STERIS. Before joining STERIS in 2004, Norton led the development of communication programs at Avery Dennison and developed media relations programs for Cedar Fair Entertainment Company. Norton is a graduate of the U.S. Army Engineering School and is a military veteran. He completed successful tours of duty with the United States Army’s 2nd Infantry Division in South Korea and the 194th Armored Brigade Command Group, based at Fort Knox, Kentucky. Additionally, he earned a bachelor’s degree in media and communications from Medaille College in Buffalo, New York, with a dual major in journalism and mass communication.
Dr. Pigott is a recognized leader in medical innovations and vascular surgery. He is founder and president of VentureMed Group, a medical device company involved in the treatment of peripheral artery disease and a founding member of Vascular Innovations, a company devoted to novel technologies for aortic aneurysms. A member of Cleveland Clinic Innovations Commercialization Advisory Board, Dr. Pigott holds his own patents for devices involving aortic aneurysm and peripheral artery technologies. He serves as a consultant to numerous multinational medical device companies and conducts national and regional new device training programs. Dr. Pigott was an early proponent of minimally invasive endovascular treatment for abdominal aortic aneurysms, carotid artery and peripheral artery disease and was a principal investigator for national clinical trials studying these techniques. He has authored multiple articles in peer-reviewed medical journals and presents at regional and national vascular meetings. As a board-certified vascular surgeon at Jobst Vascular Institute (JVI) and ProMedica Toledo Hospital, Dr. Pigott serves as a faculty member of the ACGME-accredited Jobst Vascular Fellowship Program. Dr. Pigott received his medical degree from the Medical College of Ohio, completed his residency at Akron City Hospital, and is fellowship-trained by Mayo Clinic
Aaron Pitts, Managing Director, Biohealth and Agribusiness, Food Processing, JobsOhio
As managing director, Aaron Pitts has responsibility for defining and executing growth strategies for Ohio’s Biohealth and Agribusiness and Food Processing industries. Aaron joined JobsOhio in 2013 after spending the past 12 years at Cardinal Health where he focused on strategy, business development, and general management roles for the $100b global healthcare services company. Previously, Aaron held management consulting positions with Ernst & Young and PricewaterhouseCoopers where he executed operations strategy initiatives across consumer packaged goods, food processing, healthcare, and financial services sectors. Education: University of Minnesota, MBA; The Ohio State University, BSBA.
Gordon Rosenberry is the Director, State Government Affairs for Johnson & Johnson with responsibility for all state government issues in Ohio, Kentucky and Indiana. Johnson & Johnson is the largest, most diverse healthcare company in the world with a product mix in the pharmaceutical, medical device and consumer products areas. Gordon currently is the Chair of the PhRMA SGA Task Force in Ohio and the Vice Chair of the PhRMA SGA Task Force in Kentucky. Gordon also is a member of legislative advocacy committees for BioOhio and the Indiana Medical Device Manufacturers Council. Previously, Gordon worked in the State Government Affairs area for Schering-Plough and Zeneca Pharmaceuticals. Gordon is a graduate of Wright State University with a degree in Marketing. Gordon is a lifetime resident of Ohio, born and raised in Springfield and lives with his wife Jennifer and two boys in Cincinnati.
David R. Scholl, PhD, Partner, Athenian Venture Partners
Dr. David Scholl was President/CEO of Diagnostic Hybrids, Inc. (DHI) in Athens, Ohio from 1995 to 2010. Founded in 1983, DHI grew to be a world leader in cell- and MAb-based clinical virology diagnostics. In 2010 the company was acquired by Quidel Corporation and Dave served on the Quidel senior executive team through October 2011. He is currently a healthcare partner with the venture capital firm Athenian Venture Partners. Dave serves on numerous boards including BioOhio, the Ohio Third Frontier Commission, and is a trustee of Ohio University and the Ohio University Foundation.
Mike Sieron, President and COO, P&C Pharma
Mr. Sieron has worked for a number of both publicly traded and private companies in his career including DG Medical, AcuTemp, Thermo Electron, and the Swedish company Sunds Defibrator. Mr. Sieron professional accomplishments include sitting on various Boards of Directors in fiduciary and advisory capacities, successfully executing several acquisitions, setting up various global sales networks and being awarded numerous patents. Mr. Sieron holds a Bachelor of Science degree in Mechanical Engineering and a minor in Business from the University of Cincinnati. He has continued his education with executive education courses in finance, management, and other disciplines from The Kellogg School of Management at Northwestern University and Xavier University.
Jon J. Snyder, President and CEO, Neuros Medical
Jon Snyder is the Founding President and CEO of Neuros Medical, Inc., a Cleveland, Ohio based neuromodulation company focused on developing proprietary therapies for unmet needs to patients worldwide. He holds over 20 years of global management experience in biomedical and healthcare sales, marketing, and operations with significant experience in bringing new products into the marketplace. His background covers business development, product development, market management, sales management, venture capital investment, and fundraising at start-up and Fortune 500 (Top 20) companies including Cyberonics, Cardinal Health, Imalux, and STERIS. Snyder has a B.S. from Ohio University.
Charles Steiner, Manager, Innovations Operations, Cleveland Clinic Innovations
Charles Steiner has over 25 years of experience in medical technology development. Prior to joining CCI, Charles was a product development engineer for the Center for Neurological Restoration and a business and technology developer for the Center for Minimally Invasive Surgery at Cleveland Clinic. His contributions have been in the field of surgical navigation for cranial and spinal indications, neuromodulation for movement and cognitive indications as well as neuromodulation for headache and autonomic indications. Charles received his BS in chemistry and computer science from Case Western Reserve University.
Stacy Strauss, Director, Ohio University Innovation Center
Stacy Strauss joined the Innovation Center as the Associate Director in August 2014 and was promoted to Director in October 2016. At the Innovation Center, Ms. Strauss oversees the staff, makes connections for clients, oversees facility management, fundraising efforts, budget analysis, grant writing, and other Innovation Center operations. She was instrumental in securing a $2 million dollar grant from the Appalachian Regional Commission in 2016. Ms. Strauss joined the Innovation Center from Hocking College, where she served in a dual role as a Student Affairs Coordinator and Career Services Director from April 2013 through August 2014. Ms. Strauss holds a bachelor’s degree in history from Kenyon College and a master’s degree in education from Ohio State University. She also holds a Business Incubator Management certificate from the International Business Innovation Association.
Caroline C. Whitacre, PhD, Senior Vice President for Research, The Ohio State University
Dr. Caroline Whitacre is a professor of microbial infection and immunity, and has served as the vice president for research at The Ohio State University since 2008. Her expertise on immunological mechanisms and gender differences in multiple sclerosis has made her one of the world’s most acknowledged authorities on autoimmune disease. Dr. Whitacre is responsible for the overall strategic planning and infrastructure support for the university’s $967M annual basic and applied research program. Dr. Whitacre has published extensively, is a member of various professional groups, and has many professional honors. Dr. Whitacre received her BA and PhD degrees from Ohio State and completed her postdoctoral training at Northwestern Medical School in Chicago. She joined the College of Medicine faculty in 1981.